Stock futures steady as traders await Fed rate decision, Powell’s final meeting, and Magnificent 7 earnings—plus Dimon, Baidu ...

Elicio Therapeutics (ELTX) is approaching a pivotal trial readout for its KRAS peptide vaccine, positioning 2026 as a ...

Lear (LEA) outlook: strong backlog and cash flow, but muted 2025–26 revenue growth and TAM stagnation pressure valuation.

On a pro forma basis, as at 31 March 2026, Syrah will have up to USD 178 million in liquidity and no cash interest or principal repayments for 3 years. This provides a transformational improvement in ...

BLX stays a Buy: undervalued with 13% loan growth and 24% fee income offsetting NIM pressure; ROE guided 14–15% with low ...

Federated Hermes US Strategic Dividend ETF is an actively managed ETF targeting high dividend-paying U.S. stocks with ...

Modine Manufacturing is undergoing a strategic transformation to high-margin liquid cooling solutions for AI data centers.

Q1 2026 earnings call recap: revenue up 11%, NGS mix shift, RaDaR ST traction, and raised 2026 guidance after MolDX approval—read now.

Universal Corporation's Ingredients segment shows growth potential but remains too small to offset tobacco headwinds. Read ...

The KraneShares Mount Lucas Managed Futures Index Strategy ETF seeks to track Mount Lucas Management's KFA MLM Index. Read ...

Cerrado Gold shows stronger fundamentals, spot gold upside, a 5% buyback, and a Q2 2026 BFS catalyst at Mont Sorcier. Learn ...

ClearBridge Select Strategy underperformed in a risk-off period where heightened geopolitical risk and negative sentiment ...